Inflammatory PCOS: What it Is And How to Deal with a PCOS Flare-Up
Welcome to our deep dive into the complex world of Polycystic Ovary Syndrome (PCOS) and its inflammatory nature. If you've ever wondered about the intricate connection between chronic inflammation and PCOS, you're in the right place. We'll unravel the mysteries of this common endocrine disorder, shedding light on the role of inflammation in its development and the potential complications it can cause.
In this article, we'll explore the latest research findings, including the inflammatory markers associated with PCOS and the impact of chronic low-grade inflammation on this condition. We'll also examine the potential health risks that come with PCOS, such as insulin resistance and metabolic syndrome, and how they're influenced by inflammation. But it's not all doom and gloom.
We'll also provide practical tips on how to reduce inflammation and manage PCOS symptoms effectively. So, whether you're a woman dealing with PCOS or a loved one looking to find more informtion for your partner, this blog is for you.
Click here to discover how our award winning myo-inositol PCOS Supplements with can help you.
Understanding Polycystic Ovary Syndrome (PCOS)
Polycystic Ovary Syndrome (PCOS) is a complex endocrine disorder that according to the NHS affects one in ten women during their reproductive years. It's a condition that not only impacts ovarian function but also has far-reaching implications on a woman's overall health. This section aims to provide a comprehensive understanding of PCOS, its role in women's health, and the common symptoms and diagnostic criteria associated with it.
PCOS is characterised by a variety of symptoms, including ovarian dysfunction and androgen excess. However, its impact extends beyond these symptoms, affecting various aspects of a woman's life. This is primarily due to its association with serious metabolic diseases, such as insulin resistance, which can lead to long-term cardiovascular illnesses. Despite its prevalence, the fundamental mechanisms of PCOS remain largely unknown, making it a critical area of research in women's health.
The Role of PCOS in Women's Health
PCOS is primarily associated with ovarian dysfunction, which includes symptoms such as oligo-ovulation (infrequent ovulation) and polycystic ovarian morphology (PCOM). Androgen excess, characterised by hirsutism (excessive hair growth) and hyperandrogenemia (high levels of androgens in the blood), is another distinguishing feature of PCOS.
However, the profound impact of PCOS extends beyond reproductive health. Beyond influencing the ovarian function of young women, this syndrome has lifelong implications that spill over into different aspects of a woman's life. This is because PCOS, despite being typically thought of as an ovarian syndrome, is also closely linked to serious and persistent metabolic diseases.
Insulin resistance is one such metabolic dysfunction commonly found in women with PCOS. This resistance can lead to the onset of type 2 diabetes and cardiovascular diseases. Additionally, chronic low-grade inflammation, often seen in individuals with PCOS, is believed to exacerbate these long-term cardiovascular illnesses. However, the mechanisms that trigger the onset of PCOS, despite its common nature, still largely remain a mystery.
A substantial body of research draws a connection between insulin resistance, the overproduction of androgens, and PCOS, suggesting that these factors collectively contribute to the emergence of this syndrome. Investigating and understanding these connections is crucial for managing PCOS and minimising its long-term impacts on women's health.
In summary, PCOS is a common but often underdiagnosed ovarian disorder impacting 10% of women worldwide in their reproductive age and beyond. It has pervasive implications that can disrupt a woman's ovarian function, induce endocrine disorders and promote metabolic dysfunction, spelling profound consequences for a young woman's health. PCOS should therefore be viewed and managed not just as an ovarian syndrome but as an inclusive condition with far-reaching ramifications for women's health.
Common Symptoms and Diagnostic Criteria for PCOS
When discussing Polycystic Ovary Syndrome (PCOS), understanding its symptoms and diagnostic criteria is crucial. Here are some of the common signs and symptoms related to PCOS:
Irregular or Missed Periods: A key indication of PCOS, many women suffer from inconsistent menstruation cycles, or in some cases, complete absence of periods.
Androgen Excess: Exhibited through traits like acne or excessive hair growth in areas such as the face, chest, and abdomen, or confirmed via a blood test showing elevated androgen levels.
Enlarged Ovaries: Often identified through an ultrasound, it's common for individuals with PCOS to have enlarged or polycystic appearing ovaries. However, not everyone develops cysts.
Being aware of other symptoms tied to PCOS can also help in recognising the condition:
Obesity: Between 40% and 80% of people with PCOS struggle with maintaining a healthy weight.
Acanthosis Nigricans: Darkened skin patches in areas like the folds of your neck, armpits, groin, and under the breasts are often observed in PCOS patients.
Skin Tags: These small flaps of excess skin, often found in the armpits or on the neck, are common in those with this endocrine disorder.
Hair Thinning: PCOS may result in loss of hair on the head or thinning hair.
Infertility: Often a result of irregular or infrequent ovulation, PCOS is a primary cause of infertility.
The diagnosis of PCOS requires at least two of these symptoms. Various methods like physical exams, blood and hormone level tests, and ultrasounds may be employed by a healthcare provider to confirm the condition. It's important to note that an individual can have PCOS even if they don’t exhibit any noticeable symptoms. Yet, any irregularity in menstrual cycles, difficulty in maintaining an ideal weight, or difficulties in conceiving should alert individuals to consider getting tested for PCOS. In essence, understanding the common symptoms and diagnostic criteria is the first step towards the management and treatment of this widespread condition affecting ovarian function in women of reproductive age.
PCOS as an Inflammatory Process
While it's primarily known as a hormonal disorder, recent research^1 has shed light on the significant role inflammation plays in the development of PCOS and its progression. This has led to a new perspective on PCOS, viewing it not just as a hormonal imbalance but also as an inflammatory process.
Understanding PCOS as an inflammatory process is crucial as it opens up new avenues for treatment and management. It also helps us comprehend the wide-ranging effects of this condition, which extend beyond reproductive health. This section will look at the intricacies of PCOS as an inflammatory process, exploring how inflammation contributes to the condition and its complications.
The Role of Inflammation in PCOS
The complexities of PCOS extend beyond reproductive health and play a significant role in the body's inflammatory response. PCOS is often recognised as a low-grade inflammatory disease. This means that a persistent state of inflammation defines it, leading to various systemic effects on the body. Intriguingly, inflammation isn’t just a side effect or symptom of PCOS; it actively contributes to and aggravates the condition's predominant symptoms.
Despite its classification as a reproductive disease, PCOS profoundly influences multiple body systems - and inflammation accentuates these effects. It's worth noting that the inflammation apparent in PCOS isn't a full-blown, acute inflammatory response like the one that occurs when you have an infection or a cut. Instead, it's a subtler, low-grade inflammation that persists over time - a chronic inflammatory state.
The chronic inflammation in PCOS can lead to harmful systemic effects. For instance, it may intensify insulin resistance, a common feature of PCOS. It may also magnify cardiovascular risks, contributing to atherosclerotic changes and heart disease.
This chronic inflammatory state in PCOS isn’t an isolated process restricted to the ovaries or reproductive system. Instead, it pervades the entire body and has systemic implications. For instance, the metabolic disruptions associated with PCOS, such as insulin resistance and weight gain, likely stem partly from this chronic inflammation.
Therefore, inflammation isn't merely a symptom or consequence of PCOS; it's intertwined in the condition's development and progression. In understanding PCOS as an inflammatory process, we are opening new paths to more effective and targeted treatment strategies. Recognising the central role inflammation plays in PCOS may well be key to unlocking the secrets of this multifaceted disorder.
In summary, inflammation presents a critical component of PCOS, contributing to its complex nature and wide-ranging implications. As understanding of the role of inflammation in PCOS evolves, there is hope of more personalised and effective treatments for the millions of women affected by this syndrome.
Inflammatory Markers Associated with PCOS
As we've seen, Inflammatory PCOS refers to a condition where chronic inflammation plays a significant role in the development of the syndrome.
Studies^2 have shown that women with PCOS often have higher levels of inflammatory markers in their bodies, such as C-reactive protein (CRP) and interleukin-6 (IL-6). This chronic inflammation can lead to insulin resistance and hormonal imbalances, causing symptoms like weight gain, acne, irregular periods, excessive hair growth (hirsutism) and mood swings. Here are they key inflammatory markers associated with PCOS:
C-Reactive Protein (CRP): One significant inflammatory marker associated with PCOS^3 is C-Reactive Protein (CRP). This acute-phase protein is secreted by the liver in response to inflammation, and women with PCOS often exhibit elevated CRP levels.
Leukocytes/White Blood Cells (WBCs): An increased count of leukocytes, or white blood cells, is according to research^4, commonly observed in women with PCOS. The heightened presence of these cells suggests an underlying inflammatory process, contributing to the progression of PCOS.
Interleukins: Interleukins, specifically IL-6 (Interleukin-6), IL-17 (Interleukin-17), IL-1, and IL-8 have been correlated with PCOS. IL-6 is recognised^5 as a risk factor for cardiovascular disease in women, and its elevation may be an indicator of insulin resistance. Increased levels of IL-17, IL-1, and IL-8 may signal the presence of a polycystic ovary (PCO).
Tumor Necrosis Factor (TNF): TNF (Tumor Necrosis Factor), or TNF-α, is a pro-inflammatory cytokine that, according to studies^6, shows a positive correlation with insulin resistance in PCOS patients.
Neutrophil-to-Lymphocyte Ratio (NLR): NLR is another inflammatory marker associated with PCOS^7. It indicates poor cardiovascular health and metabolic syndrome (MS). Interestingly, this ratio also plays a role in female hormonal regulation as it acts as a negative regulator for Follicle Stimulating Hormone (FSH), indirectly stimulating testosterone production.
Platelet-to-Lymphocyte Ratio (PLR): The PLR, according to studies^8, serves as an assessment parameter in evaluating the prognosis of PCOS.
Oxidative Stress Markers: Markers of oxidative stress have also been found in higher levels in women with PCOS, indicating an ongoing pro-inflammatory state.
Taking these markers into account, it's possible to infer that PCOS is indeed a systemic inflammatory disease, with these markers serving as potential indicators of the disease's severity and complications. However, it should be noted that the levels of these markers can vary individually and may also be influenced by other factors such as obesity and insulin resistance. Therefore, a thorough understanding and interpretation of these inflammatory markers is crucial in managing PCOS effectively.
Take our quiz to find the best MyOva supplement for you!
Inflammatory PCOS, its Potential Complications and How It Increases the Risk Of Other Conditions
Inflammatory polycystic ovary syndrome (PCOS) isn't a distinct type of the condition, but for a significant number of women diagnosed with PCOS, inflammation is an underlying factor that magnifies their health condition. As we've seen, emerging research affirms that women with PCOS often exhibit higher levels of inflammatory markers such as C-reactive protein (CRP), leukocytes/white blood cells (WBCs), specific interleukins, and tumor necrosis factor (TNF). This persistent, low-grade inflammation is one of the mechanisms that stimulates the onset of health complications beyond the main symptoms of the disorder.
One critical health risk associated with inflammatory PCOS is insulin resistance, the condition where the body's usual response to the hormone insulin becomes impaired. Insulin resistance is a significant health concern as it creates a cascade of metabolic problems, including an increased risk for cardiovascular disease and type 2 diabetes. Inflammatory PCOS can exacerbate insulin resistance, as the chronic inflammation is believed to negatively interfere with insulin signaling, laying the foundation for these severe health complications.
Obesity is another complication often related to inflammatory PCOS. According to clinical findings^9, the intra-abdominal fat associated with obesity is a significant source of pro-inflammatory factors, contributing to the sustained inflammation. Studies suggest that about 30% of women with PCOS have visceral fat, closely related to insulin resistance. Thus, the co-occurrence of PCOS, inflammation, and obesity creates a worrisome triad of health risks.
Chronic diseases such as atherosclerosis and coronary heart disease are also more common among women with inflammatory PCOS, and the inflammation component is believed to play a crucial role. Atherosclerosis, a condition where plaque builds up in the arteries, is strongly associated with inflammatory processes. As such, chronic inflammation characteristic of people with PCOS may escalate the progression of such diseases.
Complications like impaired glucose tolerance or prediabetes are often seen in women with PCOS. Chronic inflammation in PCOS patients increases the risk of prediabetes, which can eventually lead to full-blown diabetes if not properly managed. Increased levels of inflammation lead to a cluster of metabolic abnormalities including insulin resistance and impaired glucose tolerance, thus increasing the risk of developing type 2 diabetes.
Inflammatory PCOS can also have a serious impact on women's fertility. Inflammation associated with PCOS may interfere with the normal functioning of the ovaries, leading to ovulatory dysfunction. Increased levels of inflammation can interfere with ovarian follicle atresia, decrease apoptosis, and prevent oocyte maturation, leading to subfertility or infertility.
In summary, the chronic, low-grade inflammation seen in individuals with PCOS, known as inflammatory PCOS, is linked to an increase in numerous health risks. It works as a catalyst, accelerating the development of metabolic disorders, cardiovascular diseases, prediabetes, obesity, and fertility problems, creating a complex web of health complications. A deeper understanding of inflammatory PCOS and its potential implications is essential to anticipate and manage these health risks.
Common Complications of Inflammatory PCOS
Increased Health Risks: Women with inflammatory PCOS may experience increased health risks due to chronic inflammation. These risks extend beyond reproductive health issues, encompassing metabolic and cardiovascular conditions, which can severely impact quality of life.
Insulin Resistance: Chronic inflammation in women with PCOS often contributes to insulin resistance. This condition can lead to the overproduction of insulin, a hormone that controls blood sugar. Over time, insulin resistance can lead to the development of impaired glucose tolerance and type 2 diabetes.
Obesity: Obesity is another potential complication of inflammatory PCOS. Chronic inflammation disrupts normal metabolic processes, leading to increased fat storage and consequent weight gain. In turn, obesity can increase the risk of a host of other chronic diseases.
Cardiovascular Problems: Chronic inflammation, insulin resistance, obesity, and hormonal imbalances combined raise the risk of cardiovascular diseases, including atherosclerosis and coronary heart disease. These conditions can occur irrespective of age, emphasising the importance of early diagnosis and management.
Endothelial Dysfunction: The long-term presence of inflammation can affect the inner lining of blood vessels, leading to endothelial dysfunction. This can increase the risk of high blood pressure and other cardiovascular diseases, making the detection and treatment of PCOS crucial.
Hyperandrogenism: Excess adipose tissue can lead to increased levels of testosterone, a condition known as hyperandrogenism. This can exacerbate PCOS symptoms, further worsening inflammation and causing physical changes in appearance.
Disruptions in Mental Health: The physiological changes that PCOS brings, along with its impact on appearance and lifestyle, may contribute to disturbances in mental health. Anxiety, depression, and eating disorders have been associated with PCOS.
Increase in Cancer Risk: Some studies^10 indicate that women with PCOS may have a higher risk of developing certain types of cancer, including endometrial and ovarian cancers. This is due to the irregular menstrual cycles and high estrogen levels often associated with PCOS.
By understanding these potential complications of inflammatory PCOS, women and their healthcare providers can create comprehensive and effective treatment plans. Early diagnosis and consistent, appropriate management can significantly reduce these risks and improve the quality of life for women living with PCOS.
Ways to Lower Inflammation in PCOS
Inflammatory PCOS is a complex condition that can lead to various health complications if not managed effectively. One of the most effective ways to manage this condition is by lowering inflammation in the body. This section will delve into the various ways to lower inflammation in PCOS, focusing on dietary changes and lifestyle modifications. These strategies are not only beneficial for managing PCOS but also for improving overall health and well-being.
The connection between inflammation and PCOS is significant, and understanding this relationship can help in devising effective treatment options. By enhancing insulin sensitivity and reducing inflammation, women with PCOS can manage their symptoms and reduce the risk of associated health complications. Let's explore these strategies in detail.
Dietary Changes to Reduce Inflammation
Managing PCOS related inflammation requires various lifestyle choices, chief among them being a shift to an anti-inflammatory diet. An anti-inflammatory diet, commonly associated with the Mediterranean-style diet, has proven effective in the reduction of inflammation among people with PCOS.
Here are some dietary guidelines that can help reduce inflammation if you have PCOS:
Eat plenty of fish: Fish like salmon, rich in Omega-3 fatty acids, are known to have anti-inflammatory properties, making them an excellent choice for managing inflammation.
Include legumes and nuts in your diet: These are rich in fiber content and have anti-inflammatory properties, as well as being a great source of plant-based protein.
Use olive oil instead of saturated fats: Olive oil is an influential pillar of the Mediterranean diet and plays a crucial role in fighting inflammation.
Incorporate herbs, spices, and green tea: Adding herbs and spices not only enriches the taste of food but also enhances its nutritional profile. Similarly, green tea has anti-inflammatory properties and plenty of antioxidants.
Prefer whole fruits over sugary snacks: Fruits offer wholesome fiber and essential nutrients minus the detrimental impact of processed sugar on your insulin sensitivity.
However, just incorporating anti-inflammatory foods in your diet is not enough. Avoiding certain foods is as much a part of an anti-inflammatory diet as including others.
Some of the foods to be minimised or avoided are fried foods, red meat, processed snacks, sugary and alcoholic beverages, milk, cheese, dairy products, and foods with preservatives. All of these can spike your blood sugar or trigger inflammation leading to adverse health effects.
Increasing your intake of anti-inflammatory foods and decreasing intake of inflammation-promoting ones can significantly improve your health outcomes. Also remember, everyone's body is unique. Your body's response to different foods might vary from others. Therefore, some trial and error will go a long way in finding the anti-inflammatory diet that best works for you.
Keeping these dietary changes in mind and implementing them can be a fundamental treatment option in managing inflammation related to PCOS. It can not only help improve your hormonal balance but also enhance your overall health by boosting your insulin sensitivity, thus minimising any relation to insulin resistance. Aim to make these changes as part of your lifestyle rather than a short-term measure. It's your body; treat it right!
Exercise and Other Lifestyle Changes for Managing Inflammation
Beyond dietary adaptations, other lifestyle modifications can considerably enhance your quality of life and manage inflammation caused by PCOS. Here's an insightful list:
Engaging in Regular Physical Activity: Evidence^11 highlights that regular exercise, particularly aerobic activities, can be beneficial in diminishing inflammation linked with PCOS. High-intensity exercises such as running, swimming, high-intensity interval training (HIIT) classes, spinning, or kickboxing are notably impactful. However you don't need to do high impact exercise, low impact can be equally beneficial. Ultimately, the best type of exercise for people with PCOS is exercise that’s enjoyable. Research^12 indicates that, contrary to popular belief, there isn’t any specific type of training that’s best suited to people with PCOS. What is advised, however, is engaging in an activity that you like enough to repeat consistently. Consistency is key when it comes to reaping the rewards of exercise.
Stress Management Techniques: It's no secret that stress can amplify inflammation. Engaging in stress management activities like mindfulness or meditation can be fruitful. Practicing these methods reduces anxiety and fosters a better mental environment, assisting in the management of PCOS.
Supplementing Diet with Omega-3 fatty acids: The anti-inflammatory properties of omega-3 fatty acids have been widely recognised. These acids are considered one of the best absorbed forms of fish oil and can supplement your diet to help decrease inflammation.
Investing in Quality Sleep: Adequate rest and sleep are vital to allow the body to restore and replenish, and this can help mitigate inflammation.
Limiting Exposure to Environmental Toxins: Certain environmental toxins can exacerbate inflammation. Limiting your exposure to chemicals, endocrine disruptors, air pollution, and other environmental toxins can assist in managing inflammation.
Ensuring Proper Hydration: Staying hydrated helps in the efficient functioning of various bodily processes, and this can aid in controlling inflammation.
Consistency is key when it comes to lifestyle changes for managing PCOS-related inflammation. Gradual but steady changes will bring about lasting improvements, fostering better insulin sensitivity and managing complications arising from PCOS.
Taking Control of Inflammatory PCOS
In conclusion, understanding the connection between chronic inflammation and PCOS is crucial in managing this complex endocrine disorder. The inflammatory process, marked by increased levels of inflammatory markers, plays a significant role in the development of insulin resistance, ovarian dysfunction, and other health risks associated with PCOS. Adopting lifestyle changes such as a balanced diet and regular exercise can help reduce inflammation and improve insulin sensitivity.
It's also important to remember that each individual's journey with PCOS is unique, and what works for one may not work for another. While this blog provides a comprehensive overview of inflammatory PCOS, it's essential to consult with your doctor or a healthcare professional for personalised advice and treatment options. Stay informed, stay proactive, and remember, you're not alone in this journey.
Take our quiz to find the best MyOva supplement for you!
References:
1. Xiushen Li, Sailing Lin, Xiaolu Yang, Can Chen, Shu Cao, Qi Zhang, Jingxin Ma, Guli Zhu, Qi Zhang, Qiongfang Fang, Chunfu Zheng, Weizheng Liang, Xueqing Wu, When IGF-1 Meets Metabolic Inflammation and Polycystic Ovary Syndrome, International Immunopharmacology, Volume 138, 2024,112529, ISSN 1567-5769, https://doi.org/10.1016/j.intimp.2024.112529.
2. Escobar-Morreale HF, Luque-Ramírez M, González F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril. 2011 Mar 1;95(3):1048-58.e1-2. doi: 10.1016/j.fertnstert.2010.11.036. Epub 2010 Dec 17. PMID: 21168133; PMCID: PMC3079565.
3. Aboeldalyl S, James C, Seyam E, Ibrahim EM, Shawki HE, Amer S. The Role of Chronic Inflammation in Polycystic Ovarian Syndrome-A Systematic Review and Meta-Analysis. Int J Mol Sci. 2021 Mar 8;22(5):2734. doi: 10.3390/ijms22052734. PMID: 33800490; PMCID: PMC7962967.
4. Almaeen AH, Alduraywish AA, Nabi M, Shah NN, Shaik R, Tantry BA. Quantitative Changes in White Blood Cells: Correlation with the Hallmarks of Polycystic Ovary Syndrome. Medicina (Kaunas). 2022 Apr 12;58(4):535. doi: 10.3390/medicina58040535. PMID: 35454373; PMCID: PMC9031855.
5. Abubakar M, Rasool HF, Javed I, Raza S, Abang L, Hashim MMA, Saleem Z, Abdullah RM, Faraz MA, Hassan KM, Bhat RR. Comparative Roles of IL-1, IL-6, IL-10, IL-17, IL-18, 1L-22, IL-33, and IL-37 in Various Cardiovascular Diseases With Potential Insights for Targeted Immunotherapy. Cureus. 2023 Jul 26;15(7):e42494. doi: 10.7759/cureus.42494. PMID: 37637634; PMCID: PMC10455045.
6. Gao L, Gu Y, Yin X. High Serum Tumor Necrosis Factor-Alpha Levels in Women with Polycystic Ovary Syndrome: A Meta-Analysis. PLoS One. 2016 Oct 20;11(10):e0164021. doi: 10.1371/journal.pone.0164021. PMID: 27764100; PMCID: PMC5072730.
7. Li L, Yu J, Zhou Z. Association between neutrophil-to-lymphocyte ratio and polycystic ovary syndrome: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2022 Sep 23;101(38):e30579. doi: 10.1097/MD.0000000000030579. PMID: 36197242; PMCID: PMC9509139.
8. Pergialiotis V, Trakakis E, Parthenis C, Hatziagelaki E, Chrelias C, Thomakos N, Papantoniou N. Correlation of platelet to lymphocyte and neutrophil to lymphocyte ratio with hormonal and metabolic parameters in women with PCOS. Horm Mol Biol Clin Investig. 2018 Apr 25;34(3):/j/hmbci.2018.34.issue-3/hmbci-2017-0073/hmbci-2017-0073.xml. doi: 10.1515/hmbci-2017-0073. PMID: 29694329.
9. Jurczewska J, Ostrowska J, Chełchowska M, Panczyk M, Rudnicka E, Kucharski M, Smolarczyk R, Szostak-Węgierek D. Abdominal Obesity in Women with Polycystic Ovary Syndrome and Its Relationship with Diet, Physical Activity and Insulin Resistance: A Pilot Study. Nutrients. 2023 Aug 20;15(16):3652. doi: 10.3390/nu15163652. PMID: 37630842; PMCID: PMC10459970.
10. Shetty C, Rizvi SMHA, Sharaf J, Williams KD, Tariq M, Acharekar MV, Guerrero Saldivia SE, Unnikrishnan SN, Chavarria YY, Akindele AO, Jalkh APC, Eastmond AK, Hamid P. Risk of Gynecological Cancers in Women With Polycystic Ovary Syndrome and the Pathophysiology of Association. Cureus. 2023 Apr 7;15(4):e37266. doi: 10.7759/cureus.37266. PMID: 37162768; PMCID: PMC10164440.
11. Hafizi Moori M, Nosratabadi S, Yazdi N, Kasraei R, Abbasi Senjedary Z, Hatami R. The Effect of Exercise on Inflammatory Markers in PCOS Women: A Systematic Review and Meta-Analysis of Randomized Trials. Int J Clin Pract. 2023 Feb 9;2023:3924018. doi: 10.1155/2023/3924018. PMID: 36817281; PMCID: PMC9934983.
12. Giallauria, F., Palomba, S., Maresca, L., Vuolo, L., Tafuri, D., Lombardi, G., Colao, A., Vigorito, C. and (2008), Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS). Clinical Endocrinology, 69: 792-798.